HCIT, very sorry to hear about your kidney cancer. I do

New Post Public Reply Private Reply Replies (0) Message Board
Cassandra X HCIT #113483
873
HCIT, very sorry to hear about your kidney cancer. I do hope you get access to Leronlimab but in the mean time -

IF I WERE IN YOUR SHOES -

I would have my doctor or another doctor put me on Maraviroc immediately. The liver toxicity issue is exaggerated and would be of no concern for three reasons - the dire situation I was in, I could monitor for liver damage with blood tests and toxicity to the liver from cancer treatments would be much worse.

I would double up on the Maraviroc dosage, at least, as I am doing the blood tests, and I would still press hard for Leronlimab. If I couldn't get the LL, I'd make the hard choice and take more Maraviroc, as much as my liver would allow.

Too bad Maraviroc isn't the elegant molecule that LL is but it is a CCR5 antagonist. If it helped, I would pretend I was in Phase 2 trial, looking for the best dosage level. Put me on the high dose.

The biggest obstacle I would find to doing this would be the doctors and hospitals trying to cover their asses. I would seek legal help if I needed to and sign any waivers I had to. Ass covering will be a problem with LL too, maybe more so because it is not an approved drug yet.

That's what I would do. Enuf said.

Best wishes to you and please keep us here on the board informed.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Preplanning Funerals: Choices for Clarity and Comfort

Updated Category News Views 41

Making Clear Plans for the Inevitable Man, if life is certain about one thing, it’s the endgame. And nobody wants to pass the buck on sorting out the details when they’re six feet under. Enter funeral preplanning – a chance to write the script for your own final episode and keep your family out of the weeds when the time comes. Jake Leonetti over at Stone Chapel...

Continue Reading
HashKey and AMBR Unite to Push AI Frontiers in Finance

Updated Category News Views 60

Shaping the Future with AI Integration In the whirlwind of innovation, there's always the ones braving the frontier, pushing the very boundaries of what we deem possible. Today, it's HashKey Capital and AMBR joining forces, marching into uncharted financial territories. This partnership is more than just a signature on a piece of paper; it's a declaration—a commitment...

Continue Reading
Metacon Q3 Report Unveiled Amid Green Hydrogen Buzz

Updated Category News Views 127

Peeling Back Metacon's Q3 2026 Figures Alright, let's sink our teeth into the meat and potatoes of Metacon's latest report. The interim report for Q3 2026 hit the newsstands, but it's what's lurking behind the numbers that tells the real story. With all the green energy buzz, Metacon's report is a mixed bag, reflecting their uphill journey in hydrogen pursuits and...

Continue Reading
Personalized Brain Stimulation: Hope for Mental Health?

Updated Category News Views 7

Brain Stimulation Tailored to the Individual Picture this—mental health treatments that don’t just throw a one-size-fits-all solution at you. That's what's cooking at NUH and NUS Medicine in Singapore, where innovative minds are diving deep into personalized brain stimulation. Regular transcranial magnetic stimulation (TMS) has been around, helping somewhat, but it...

Continue Reading
CVS Health Boosts 2026 Guidance Amid Revenue Jump

Updated Category News Views 89

A Solid Quarter for CVS Health CVS Health Corporation has once again turned heads with its third-quarter 2026 results. When you're pulling $108.4 billion in quarterly revenue, up 5.4% from last year, folks notice. Adjusted earnings hit $2.09 per share, climbing a respectable 30% from $1.60 the year before. The cherry on top? A big fat boost in 2026 guidance, signaling...

Continue Reading
Nomad Foods' Battle with Margins Amid Flat Volumes

Updated Category News Views 88

Subtle Winds of Change in Nomad Foods' Financials Ah, Nomad Foods—Europe's frozen food titan, trotting out its third quarter numbers like a well-rehearsed production line. You've got your slight revenue bump of 2.3% on reported streams, hitting €770 million. But dig a little deeper and you find organic revenue doing a waltz at 1.6% year-on-year, surprising no one...

Continue Reading
EXPO 2027 Belgrade: Serbia's Tourism Game-Changer?

Updated Category News Views 104

An Unexpected Stage: Belgrade's Big Show Well, who's betting on Belgrade making waves in the global travel scene? EXPO 2027 is shaping up to do just that, and it’s taking the scenic route. Serbia, a country not always on the grand tourist itineraries, could finally hog the spotlight come 2027. Under the banner of 'Play for Humanity: Sport and Music for All,' they're...

Continue Reading
Riley Permian's Q3: Cash Flow Boost & Debt Cut

Updated Category News Views 122

Riley Permian is striding with a swagger through the third quarter of 2026, and you’ve got to tip your hat to them for all the right moves. But don’t get comfy, there's a fair bit to unpack, and not all of it will make you want to reach for the champagne. Oil Production and Cash Flow Surge Setting the pace, Riley cranked up oil production by a hearty 20% from the...

Continue Reading
Manulife's Q3 2026: Strong Gains Amid Income Dip

Updated Category News Views 61

Manulife's Resilience in a Volatile Market Trading has a way of keeping folks on their toes. Just when you think you've ridden the bull long enough, it tries bucking you off. That's how it goes for Manulife Financial Corporation (TSX/NYSE/PSE: MFC), as they reported their Q3 2026 results—marking a seesaw of gains and losses. Core Earnings Shine While Net Income Declines...

Continue Reading
Cooper Standard Faces Challenges Despite New Business Wins

Updated Category News Views 51

Cooper Standard's Balancing Act Alright, let’s cut straight to the chase. Cooper Standard (NYSE: CPS) finds itself dabbling in a tricky dance—juggling sparkling new business awards while grappling with stubborn inflationary headwinds and a kick to the shin from production volume shortfalls. Third quarter of 2026, and they reported net new business awards worth a hefty...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Exciting Partnership Between Domino's and Netflix

Updated Category News Views 257

Exciting Collaboration: Domino's Pizza and Netflix Domino's Pizza Inc. (NYSE: DPZ) has teamed up with Netflix Inc. (NASDAQ: NFLX) in a thrilling initiative that merges the worlds of pizza and entertainment. This unique partnership aims to highlight how Emergency Pizza can make a difference, particularly for fans navigating the intense challenges of the popular show, Squid...

Continue Reading
Understanding Rep. Robert Bresnahan's Recent Alibaba Stock Purchase

Updated Category News Views 236

Rep. Robert Bresnahan's Investment in Alibaba Group Holdings Recently, Representative Robert Bresnahan made headlines through a reported stock purchase in Alibaba Group Holdings (NASDAQ: BABA). This acquisition, valued between $7,007 and $105,000, signals a notable move by the congressman aimed at capitalizing on the potential growth of this tech giant. The report...

Continue Reading
SP Group A/S Unveils Strategic Share Buy-Back Initiative

Updated Category News Views 122

SP Group A/S Launches Share Buy-Back Programme SP Group A/S has recently taken a significant step aimed at enhancing shareholder value through a newly initiated share buy-back programme. This initiative is indeed a forward-looking strategy designed to make the most of the financial market conditions present. Details of the Buy-Back Programme According to the established...

Continue Reading
Concerns Grow Over Anti-Fluoride Actions and Public Health

Updated Category News Views 166

Concerns Grow Over Anti-Fluoride Actions and Public Health Tooth decay remains a prevalent issue for many, representing the most common chronic disease among children and adults across the United States. Health experts, including Health and Human Services Secretary Robert F. Kennedy Jr., emphasize the need for federal health agencies to prioritize disease prevention,...

Continue Reading
Future Trends of CNC Tool Grinders Market Growth Insights

Updated Category News Views 209

CNC Tool Grinders Market Overview The global CNC tool grinders market is set for impressive growth. Increased demand for precision tooling across various industries, such as aerospace and automotive, is a main driver. The market value is expected to rise significantly, indicating strong growth potential for stakeholders involved in this field. Growth Projections and...

Continue Reading